Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-Vedolizumab Antibody (3Y834)
😃Good
Catalog No. TMAS-00117
Alias MLN-002, MLN002, MLN-0002, LDP-02, LDP02, Entyvio
Anti-Vedolizumab Antibody (3Y834) is a Rabbit antibody targeting Vedolizumab. Anti-Vedolizumab Antibody (3Y834) can be used in ELISA, Sandwich ELISA.
Anti-Vedolizumab Antibody (3Y834)
Anti-Vedolizumab Antibody (3Y834)
😃Good
Catalog No. TMAS-00117Alias MLN-002, MLN002, MLN-0002, LDP-02, LDP02, Entyvio
Anti-Vedolizumab Antibody (3Y834) is a Rabbit antibody targeting Vedolizumab. Anti-Vedolizumab Antibody (3Y834) can be used in ELISA, Sandwich ELISA.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 40 μg | $609 | 7-10 days | 7-10 days |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-Vedolizumab Antibody (3Y834) is a Rabbit antibody targeting Vedolizumab. Anti-Vedolizumab Antibody (3Y834) can be used in ELISA, Sandwich ELISA. |
| Synonyms | MLN-002, MLN002, MLN-0002, LDP-02, LDP02, Entyvio |
| Ig Type | IgG, κ |
| Clone | 3Y834 |
| Specificity | Vedolizumab |
| Application | |
| Recommended Dose | ELISA: 0.01-1 µg/ml; Sandwich ELISA: 0.5-2 μg/ml |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Purification | Protein A affinity column |
| Appearance | Lyophilized. Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/mL. |
| Formulation | Lyophilized with PBS, pH 7.2, containing 0.02% sodium azide. |
| Research Background | Vedolizumab is a humanized monoclonal antibody used primarily for the treatment of inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis. The drug functions by specifically targeting the integrin α4β7, a molecule that facilitates the migration of white blood cells into the gastrointestinal (GI) tract. By blocking this interaction, Vedolizumab reduces inflammation within the GI tract, providing relief from the symptoms associated with IBD. The drug is administered intravenously and is known for its gut-selective mechanism of action, which limits systemic immune suppression and focuses treatment effects on the GI tract. It was approved by the FDA in 2014 and is marketed under the brand name Entyvio. |
| Conjucates | Unconjugated |
| Immunogen | Vedolizumab |
Stability & Storage
| Stability & Storage | The lyophilized product store at -20°C or -80°C for 12 months. The reconstituted antibody can be stored at 2°C-8°C for 2-3 weeks or at -20°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-Vedolizumab Antibody (3Y834) | purchase Anti-Vedolizumab Antibody (3Y834) | Anti-Vedolizumab Antibody (3Y834) cost | order Anti-Vedolizumab Antibody (3Y834)
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.